Check Brainstorm Cell Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$-
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Brainstorm Cell Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
$- | NA | NA | 0.00% |
Based on 6 analysts
0.00%
Buy
50.00%
Hold
50.00%
Sell
Based on 6 analysts, 50% of analysts recommend a 'SELL' rating for Brainstorm Cell Therapeutics Inc. Average target price of $13.12
Get share price movements and forecasts by analysts on Brainstorm Cell Therapeutics Inc.
What analysts predicted
94.89%UPSIDE
Target Price
$13.12
Current Price
$0.67
Analyzed by
6 Analysts
Target
$13.12
Brainstorm Cell Therapeutics Inc target price $13.12, a slight upside of 94.89% compared to current price of $0.67. According to 6 analysts rating.
All numbers in Millions USD
All numbers in Millions USD
Organisation | Brainstorm Cell Therapeutics Inc |
E-voting on shares | Click here to vote |
Brainstorm Cell Therapeutics Inc share price today is $0.67 as on at the close of the market. Brainstorm Cell Therapeutics Inc share today touched a day high of $0.58 and a low of $0.58.
Brainstorm Cell Therapeutics Inc share touched a 52 week high of $3.97 on and a 52 week low of $0.72 on . Brainstorm Cell Therapeutics Inc stock price today i.e. is closed at $0.67,which is 83.14% down from its 52 week high and -7.37% up from its 52 week low.
Indian investors can start investing in Brainstorm Cell Therapeutics Inc (BCLI) shares with as little as ₹88.114 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Brainstorm Cell Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Brainstorm Cell Therapeutics Inc share’s latest price of $0.67 as on September 19, 2025 at 1:24 am IST, you will get 14.9254 shares of Brainstorm Cell Therapeutics Inc. Learn more about
fractional shares .